05/18/2024
Addiction Medication Offers New Hope for Long COVID Patients
Researchers discovered a promising treatment for long COVID and ME/CFS through the restoration of ion channel function in immune cells using low-dose Naltrexone.
The study extends previous research that showed similar ion channel dysfunctions in both long COVID and ME/CFS patients.
By successfully applying a drug originally used for opioid addiction, the team has demonstrated potential for significant symptom relief, including reducing brain fog and muscle fatigue.
With clinical trials set to begin, this innovative approach offers hope for improving the quality of life for individuals suffering from these debilitating conditions.